Funding for cell therapy trial
CRM Prof Stuart Forbes said: “If successful, we hope this could offer a new way to tackle liver cirrhosis.”
Tyson Ruetz wins Wilmut Prize
Tyson said: “I am incredibly honored to have won this prize! It makes it even more special to have received the award directly from Prof Sir Ian Wilmut.”
Cited2 regulator of ES cell functions
Prof Kamil Kranc said: “This study implies that Cited2 is a critical and universal master regulator of stem cell functions, an essential step in the development of new stem cell treatments and cancer therapies.”
New GSK collaboration
CRM researcher Dr Anna Williams commented: "We are excited to accelerate the development of new treatments for diseases where myelin regeneration is important."